13F-HR filed by Omega Fund Management, LLC
Omega Fund Management, LLC filed this 13F-HR for the quarter ended 2021-12-31, filed 2022-02-14, with 22 holding rows worth $707,271,000.
- Accession
- 0000950123-22-002360
- Filer
- CIK 1637359
- Filed
- 2022-02-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2021
A holdings report, 22 entries on the cover page, a total value of $707,271,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $707,272,000 with VALUE read as thousands by filing date, 13F file number 028-16844. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| NUVATION BIO INC COM CL A | 67080N101 | Stock | 22,957,340 | $195,137,000 | thousands by filing date | |
| REPLIMUNE GROUP INC | 76029N106 | COMMON STOCK | 4,763,380 | $129,088,000 | thousands by filing date | |
| IMAGO BIOSCIENCES INC | 45250K107 | COM | 3,018,737 | $71,574,000 | thousands by filing date | |
| MORPHIC HLDG INC | 61775R105 | COM | 1,200,014 | $56,857,000 | thousands by filing date | |
| KRONOS BIO INC | 50107A104 | COM | 3,818,283 | $51,890,000 | thousands by filing date | |
| GOSSAMER BIO INC COM | 38341P102 | Stock | 3,164,835 | $35,794,000 | thousands by filing date | |
| IKENA ONCOLOGY INC | 45175G108 | COM | 2,249,123 | $28,204,000 | thousands by filing date | |
| ALPINE IMMUNE SCIENCES INC | 02083G100 | COM | 2,029,580 | $28,110,000 | thousands by filing date | |
| IMMUNIC INC | 4525EP101 | COM | 1,788,160 | $17,113,000 | thousands by filing date | |
| SANA BIOTECHNOLOGY INC | 799566104 | COM | 843,750 | $13,061,000 | thousands by filing date | |
| ARCUTIS BIOTHERAPEUTICS INC | 03969K108 | COM | 623,836 | $12,938,000 | thousands by filing date | |
| ICOSAVAX INC | 45114M109 | COM | 426,395 | $9,756,000 | thousands by filing date | |
| SPRUCE BIOSCIENCES INC | 85209E109 | COM | 2,161,022 | $9,638,000 | thousands by filing date | |
| THESEUS PHARMACEUTICALS INC | 88369M101 | COM | 711,479 | $9,022,000 | thousands by filing date | |
| PARATEK PHARMACEUTICALS INC | 699374302 | Equity | 1,971,241 | $8,851,000 | thousands by filing date | |
| SYROS PHARMACEUTICALS INC | 87184Q107 | COM | 2,512,705 | $8,191,000 | thousands by filing date | |
| OMEGA ALPHA SPAC | G6749V107 | CL A | 501,000 | $4,895,000 | thousands by filing date | |
| ESSA PHARMA INC | 29668H708 | COM NEW | 328,196 | $4,660,000 | thousands by filing date | |
| INVIVYD INC | 00534A102 | COMMON STOCK | 632,855 | $4,595,000 | thousands by filing date | |
| CHECKMATE PHARMACEUTICALS IN | 162818108 | COM | 1,335,050 | $3,832,000 | thousands by filing date | |
| JOUNCE THERAPEUTICS INC | 481116101 | COM | 275,513 | $2,301,000 | thousands by filing date | |
| IMMUNOCORE HLDGS PLC ADS | 45258D105 | ADR | 51,535 | $1,765,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0000950123-22-002360 | this filing | 2022-02-14 | acceptance time not in the bulk data set |